|
|
Home >
Health Condition > Alzheimer's Disease
> Reminyl
Reminyl/Razadyne® (galantamine hydrobromide) (Janssen
Pharmaceuticals, Titusville, New Jersey, 5/01)
Related Topics:
Where to purchase:
News & Research:
-
Galantamine Effective, Well Tolerated in Patients with Alzheimer's Disease
Unresponsive to Other Antidementia Medications - Doctor's Guide, 8/30/07
-
Trio of Drugs May Improve Alzheimer's - WebMD, 1/25/06
-
Cholinesterase inhibitors for patients with Alzheimer's disease: systematic
review of randomised clinical trials - BMJ. 2005 Aug 6;331(7512):321-327
- "Because of flawed methods and small clinical
benefits, the scientific basis for recommendations of cholinesterase
inhibitors for the treatment of Alzheimer's disease is questionable"
-
Razadyne ER (Galantamine Hydrobromide), Once-Daily Treatment, Now Available
for Patients With Mild to Moderate Alzheimer's Disease - Doctor's Guide,
5/23/05
-
Reminyl Renamed Razadyne to End Mix-Ups With Diabetes Rx - Clinical
Psychiatry News, 5/05
-
Alzheimer's Drug Linked to Higher Mortality - Clinical Psychiatry News,
3/05
-
Long-Term Treatment With Reminyl (Galantamine) May Be Associated With
Reduced Risk Of Institutionalisation In Patients With Dementia -
Doctor's Guide, 11/9/04
-
Galantamine Shows Safety and Efficacy As Tx for Dementia With Lewy Bodies
- Clinical Psychiatry News, 10/04
-
Dementia Drug Ineffective for Chronic Fatigue Syndome - HealthDay,
9/7/04
-
Patients with Alzheimer's Disease who Discontinue Reminyl (Galantamine)
Treatment with Seem to Experience Cognitive Decline - Doctor's Guide,
8/23/04
-
Reminyl (Galantamine) May Help Patients With Alzheimer's Disease to Maintain
Activities of Daily Living - Doctor's Guide, 8/23/04
-
Switch Safe from Donepezil to Galantamine - Doctor's Guide, 5/19/04
-
Galantamine Confers Benefits in Patients With Pure Vascular Dementia -
Doctor's Guide, 4/29/04
-
Reminyl (Galantamine) May Reduce Specific Behavioral Symptoms in Patients
With Alzheimer's Disease - Doctor's Guide, 4/19/04
-
Mild Alzheimer's Disease May Respond Well to Galantamine - Clinical
Psychiatry News, 4/04
- Cognitive Benefits of
Galantamine Sustained During Long-term Use - Medscape, 2/20/04
-
Continuous Galantamine Therapy Slows Cognitive Decline In Alzheimer's
Disease for Up to 3 Years - Doctor's Guide, 2/18/04
-
Long-term Galantamine Shows Continued Safety, Efficacy in Patients with
Vascular Dementia or Alzheimer's Disease with Cerebrovascular Disease -
Doctor's Guide, 12/19/03
- ADHD
Symptoms Respond To Cholinergic Drugs - Psychiatric News, 11/21/03
-
Patients Treated With Alzheimer's Drug Reminyl (Galantamine HBr) Require
Less Caregiver Time - Doctor's Guide, 10/28/03
-
Drug Interactions with Cholinesterase Inhibitors: a Review - Doctor's
Guide, 10/23/03
-
Long-term Benefits of Galantamine Treatment for Patients with Vascular
Dementia or Alzheimer's disease - Doctor's Guide, 9/23/03
-
Long-Term Galantamine Therapy Safe, Effective for Dementia Patients -
Doctor's Guide, 8/6/03
-
Start Cholinesterase Inhibitor Immediately After Alzheimer's Dx -
Clinical Psychiatry News, 6/03
-
Long-Term Benefits Seen from Galantamine in Mild to Moderate Alzheimer's
Disease - Doctor's Guide, 5/26/03
-
Galantamine Achieves Sustained Cognitive Benefits for Alzheimer's Patients
- Doctor's Guide, 5/17/03
-
Antipsychotics Effective for Elderly Patients With Dementia -
Psychiatric News, 4/18/03 -
"atypical
antipsychotics have been used to alleviate deteriorating behavioral
symptoms in dementia patients, such as agitation and aggression. New
research that she cited shows some atypical antipsychotics can actually
improve cognition through activating the release of acetylcholine in the
cortex. Clozapine,
olanzapine, and risperidone,
she reported, robustly increased acetylcholine release in the cortex, while
ziprasidone only moderately increased
levels, compared with haloperidol
and thioridazine, which did not elevate acetylcholine levels at all ...
atypical antipsychotics increase cortical dopamine and
cholinesterase inhibitors at the very least increase cortical
acetylcholine action, leading to an improvement in memory and thinking, as
well as improvement in psychosis and behavior"
-
Galantamine May Provide Long-term Non-cognitive Benefits in Alzheimer's
Disease - Doctor's Guide, 3/6/03
-
Galantamine Effective Long-term in Treating Vascular Dementia or Alzheimer's
Disease - Doctor's Guide, 3/5/03
-
Alzheimer’s Drugs May Offer Psychiatric Benefits - psychiatryonline.org,
2/7/02
-
Drug Update: Alzheimer's Disease - Clinical Psychiatry News, 2/03
- Alzheimer's
Drugs Help More Than Memory - WebMD, 1/7/03 -
"Four such drugs have been approved by the FDA for
use in the U.S. -- Reminyl, approved
in 2001; Exelon, approved in 2000;
Aricept, approved in 1996; and Cognex, approved in 1993, but rarely used
now because it can cause liver problems ... treatment with one of these
drugs for at least one month slowed the worsening of functional skills such
as the ability to dress, bathe and shop. And it improved psychiatric
symptoms including depression,
hallucinations, delusions,
anxiety, and apathy"
-
Galantamine's Long-Term Safety, Efficacy In Alzheimer's Confirmed -
Doctor's Guide, 10/15/02
-
Effectiveness of Galantamine is Not Altered by Disease Severity -
Doctor's Guide, 10/14/02
-
Galantamine Delays Decline in Cognition by 12 to 18 Months - Doctor's
Guide, 10/9/02
-
Cognitive Decline Rapid and not Regained Following Discontinuation of
Acetylecholinesterase Inhibitors - Doctor's Guide, 7/22/02
-
Galantamine More Efffective and Less Costly Than Other Drugs in its Class
- Doctor's Guide, 7/22/02
-
Galantamine Hydrobromide Delays Alzheimer's Symptoms by 18 Months -
Doctor's Guide, 5/23/02
- Study Suggests Reminyl May
Provide Long-Term Benefits in Treating Alzheimer's Disease - Doctor's
Guide, 5/22/02
-
Galantamine Improves Broad Spectrum of Symptoms in Elderly Patients with
Alzheimer's Disease - Doctor's Guide, 5/15/02
-
Acetylcholinesterase Inhibitors Improve Behavior - Clinical Psychiatry
News, 4/02
- Galantamine Shows Lasting
Benefits in Alzheimer's Disease Patients - Doctor's Guide, 4/18/02
- Aricept Wins
First Head-to-Head Match-Up Against Reminyl - WebMD, 4/12/02
-
Galantamine Showing Early Promise In Some Dementias - Doctor's Guide,
4/11/02
- Aricept (Donepezil)
Significantly Improves Cognition/Daily Living over Reminyl (Galantamine) in
Alzheimer's Disease - Doctor's Guide, 4/4/02
- Reminyl (Galantamine) May
Ease Both Patient/Caregiver Burden in Alzheimer’s - Doctor's Guide,
9/14/01
- New Alzheimer’s Drug,
Reminyl (Galantamine), Effective in Mixed/Vascular Dementia - Doctor's
Guide, 6/19/01
- Alzheimer's Drug:
Benefits Seen for Two Years, Advantages of Reminyl Are Modest, Though -
WebMD, 5/16/01 -
"At the end of two years, those who took the drug
throughout the study had on average slightly less than half the degree of
decline in mental function and physical abilities of those who initially
received the placebo pill"
- Drug Therapy [Reminyl
(galantamine hydrobromide)] Can Treat Dementia In Patients With
Cerebrovascular Disease - Doctor's Guide, 5/10/01
- FDA Approves Reminyl
(Galantamine Hydrobromide) For Mild To Moderate Alzheimer’s Disease -
Doctor's Guide, 3/1/01
- Reminyl (Galantamine)
Offers Hope In Alzheimer's Disease - Doctor's Guide, 6/26/00
- Galantamine improves
symptoms of Alzheimer's - Doctor's Guide, 5/5/00
- Investigational
Alzheimer’s Drug, Reminyl (Galantamine), Improves Memory And Behavior -
Doctor's Guide, 4/7/00
- Galantamine Improves Memory
And Learning Ability In Alzheimer’s Patients - Doctor's Guide, 7/20/98
Abstracts:
|
|